Skip to main content

Aromics recieves 1 M€ from the European Union to boost its drug against the asbestos-related hallmark cancer

< Back to news
 14.02.2019

Aromics recieves 1 M€ from the European Union to boost its drug against the asbestos-related hallmark cancer